AI Model for Cervical Cancer Detection From Colposcopy Images
Launched by BANGLADESH UNIVERSITY OF ENGINEERING AND TECHNOLOGY · Oct 14, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new artificial intelligence (AI) model designed to help detect cervical cancer by analyzing images taken during a procedure called colposcopy. Colposcopy allows doctors to closely examine the cervix for signs of cancer, but results can vary depending on the doctor's skills. The goal of this study is to see if the AI can provide more accurate and consistent results, especially in areas where access to healthcare is limited. By improving the detection of cervical abnormalities, the trial aims to make screening easier and more reliable, which could lead to earlier treatment and better outcomes for women.
To participate in this trial, women must be at least 18 years old and willing to undergo cervical cancer screening. They should not have had a hysterectomy or a current diagnosis of cervical cancer. Unfortunately, pregnant women and those with certain medical conditions that could affect the screening results cannot take part. Participants can expect to have their colposcopy images analyzed by the AI model, and the study will assess how well the AI performs compared to traditional methods. Overall, this research hopes to enhance cervical cancer screening and ultimately save lives.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients of age 18 years or older can be selectedas subjects.
- • Individuals willing to participate in cervical cancerscreening.
- • Availability for colposcopic examination.
- • Women with no history of hysterectomy (total removalof the uterus).
- • Women with no current or prior diagnosis of cervicalcancer.
- • Availability of relevant medical records forconfirmation and comparison purposes.
- Exclusion Criteria:
- • Pregnant women, given the potential impact onscreening results and the need for specialconsiderations during pregnancy.
- • Individuals with severe medical conditions orcircumstances that may make colposcopic examinationinappropriate or unsafe.
- • Patients with conditions that could interfere with theaccuracy of the screening results, such as severevaginal bleeding.
- • Follow-up screenings.
About Bangladesh University Of Engineering And Technology
The Bangladesh University of Engineering and Technology (BUET) is a premier institution dedicated to advancing engineering and technology in Bangladesh through research and innovation. As a clinical trial sponsor, BUET leverages its robust academic resources and interdisciplinary expertise to conduct high-quality research that addresses critical health challenges. The university is committed to ethical standards and regulatory compliance, ensuring that all trials contribute valuable insights to the scientific community while prioritizing participant safety and well-being. Through collaboration with healthcare professionals and researchers, BUET aims to foster advancements in medical science and improve healthcare outcomes in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dhaka, , Bangladesh
Patients applied
Trial Officials
Taufiq Hasan, Taufiq
Principal Investigator
Department of Biomedical Engineering, BUET, Dhaka - 1205.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported